Microgest Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Micronised progesterone

Indications/Uses

Progesterone-deficiency related disorders. Oral: Menstrual irregularity due to dysovulation. Vag: In vitro fertilization (IVF) cycles; alternative to oral route if not tolerable.

Dosage/Direction for Use

Progesterone insufficiencies 200-300 mg daily in 1 or 2 divided doses. May increase dose to 600 mg daily in 3 divided doses, in case of aiding pregnancy. Vag Insert 1 cap deeply in the vag. Duration of treatment depends on indication & efficacy of treatment. Do not >200 mg/intake.

Contraindications

Hypersensitivity to progesterone & peanuts. Undiagnosed vag bleeding, mammary or genital tract carcinoma, thrombophlebitis, thromboembolic disorder, cerebral hemorrhage, porphyria. Severe hepatic dysfunction.

Special Precautions

Post-menopause women; conditions that might aggravate fluid retention eg, HTN, cardiac & renal disease, epilepsy, migraine, asthma; history of depression, diabetes, migraine or photosensitivity. May affect ability to drive or operate machinery. Mild to moderate hepatic dysfunction. Pregnancy & lactation.

Adverse Reactions

Acne, urticaria, rashes, fluid retention, wt changes, GI disturbances, breast discomfort, premenstrual syndrome, chloasma, depression, pyrexia, insomnia, alopecia, hirsutism; VTE. Oral: Altered menstrual cycles, amenorrhea, intermenstrual bleeding, headaches. Vag: Local irritation.

View ADR Reporting Link

Drug Interactions

Bromocriptine, cyclosporine, rifamycin.

MIMS Class

Oestrogens, Progesterones & Related Synthetic Drugs

ATC Classification

G03DA04 - progesterone ; Belongs to the class of pregnen (4) derivative progestogens.

Regulatory Classification

Presentation/Packing

Form

Microgest softcap 100 mg

Packing/Price

2 × 10's

Form

Microgest softcap 200 mg

Packing/Price

1 × 8's;7's

Microgest

progesterone

Manufacturer:

Lapi